[
  {
    "ts": null,
    "headline": "Tracking Ron Baron's BAMCO Portfolio - Q4 2024 Update",
    "summary": "BAMCO's latest 13F portfolio grew to $38.69B. Notable stake increases include CoStar Group, Vail Resorts, Hyatt Hotels, and Idexx Labs. See more here.",
    "url": "https://finnhub.io/api/news?id=e92aeb16300be7da14b7cf2c76b2ec3800c35765e628dbd315db11a00d6dee5a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741897863,
      "headline": "Tracking Ron Baron's BAMCO Portfolio - Q4 2024 Update",
      "id": 133165250,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1056792912/image_1056792912.jpg?io=getty-c-w1536",
      "related": "IDXX",
      "source": "SeekingAlpha",
      "summary": "BAMCO's latest 13F portfolio grew to $38.69B. Notable stake increases include CoStar Group, Vail Resorts, Hyatt Hotels, and Idexx Labs. See more here.",
      "url": "https://finnhub.io/api/news?id=e92aeb16300be7da14b7cf2c76b2ec3800c35765e628dbd315db11a00d6dee5a"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors",
    "summary": "IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=b9a0d40a5703f9836c914edbc7378968e7a855fc2392c0ebf48310a0977fa9f8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741884960,
      "headline": "IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors",
      "id": 133227575,
      "image": "",
      "related": "IDXX",
      "source": "MarketWatch",
      "summary": "IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=b9a0d40a5703f9836c914edbc7378968e7a855fc2392c0ebf48310a0977fa9f8"
    }
  },
  {
    "ts": null,
    "headline": "Zoetis: Focusing On The High Margin Segments",
    "summary": "Zoetis divests its MFA segment to boost margins while focusing on profitable areas like genetics. Click here to find out why ZTS stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=35dc1fed79052459e9b78cc2879075f36192e215b272ac9c991dfb99ee4f59a2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741883752,
      "headline": "Zoetis: Focusing On The High Margin Segments",
      "id": 133164243,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/500782479/image_500782479.jpg?io=getty-c-w1536",
      "related": "IDXX",
      "source": "SeekingAlpha",
      "summary": "Zoetis divests its MFA segment to boost margins while focusing on profitable areas like genetics. Click here to find out why ZTS stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=35dc1fed79052459e9b78cc2879075f36192e215b272ac9c991dfb99ee4f59a2"
    }
  }
]